JPWO2025105377A1 - - Google Patents

Info

Publication number
JPWO2025105377A1
JPWO2025105377A1 JP2025534818A JP2025534818A JPWO2025105377A1 JP WO2025105377 A1 JPWO2025105377 A1 JP WO2025105377A1 JP 2025534818 A JP2025534818 A JP 2025534818A JP 2025534818 A JP2025534818 A JP 2025534818A JP WO2025105377 A1 JPWO2025105377 A1 JP WO2025105377A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025534818A
Other languages
Japanese (ja)
Other versions
JPWO2025105377A5 (https=
JP7791559B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2025105377A1 publication Critical patent/JPWO2025105377A1/ja
Publication of JPWO2025105377A5 publication Critical patent/JPWO2025105377A5/ja
Application granted granted Critical
Publication of JP7791559B2 publication Critical patent/JP7791559B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2025534818A 2023-11-13 2024-11-12 Ｅｐｓｔｅｉｎ－Ｂａｒｒウイルス複製阻害剤 Active JP7791559B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023193086 2023-11-13
JP2023193086 2023-11-13
PCT/JP2024/040210 WO2025105377A1 (ja) 2023-11-13 2024-11-12 Ｅｐｓｔｅｉｎ－Ｂａｒｒウイルス複製阻害剤

Publications (3)

Publication Number Publication Date
JPWO2025105377A1 true JPWO2025105377A1 (https=) 2025-05-22
JPWO2025105377A5 JPWO2025105377A5 (https=) 2025-10-15
JP7791559B2 JP7791559B2 (ja) 2025-12-24

Family

ID=95742274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025534818A Active JP7791559B2 (ja) 2023-11-13 2024-11-12 Ｅｐｓｔｅｉｎ－Ｂａｒｒウイルス複製阻害剤

Country Status (2)

Country Link
JP (1) JP7791559B2 (https=)
WO (1) WO2025105377A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3181118A1 (en) * 2015-12-14 2017-06-21 Warszawski Uniwersytet Medyczny Synergistic combination of txnr inhibitors and ascorbate for treatment of b cell malignancies

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3181118A1 (en) * 2015-12-14 2017-06-21 Warszawski Uniwersytet Medyczny Synergistic combination of txnr inhibitors and ascorbate for treatment of b cell malignancies

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHAKRAVARTY S., ET AL.: "Autographic checks and balances of cellular immune responses", AUTOGRAPHY REPORTS, vol. 1, no. 1, JPN6024052518, 2022, pages 83 - 87, ISSN: 0005739088 *
EWEAS, A. F., ET AL.: "Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-Cov-2", CURRENT ISSUES IN MOLECULAR BIOLOGY, vol. 44, JPN6024052517, 4 July 2022 (2022-07-04), pages 3018 - 3029, ISSN: 0005739089 *
LIU W., ET AL.: "Structures of capsid and capsid-associated tegument complex inside the Epstein-Barr virus", NATURE MICROBIOLOGY, vol. 5, JPN6024052519, October 2020 (2020-10-01), pages 1285 - 1298, ISSN: 0005739087 *
TEITELL, M.A., ET AL.: "TCL1 Expression and Epstein-Barr Virus Status in Pediatric Burkitt Lymphoma", AMERICAN JOURNAL OF CLINICAL PATHOLOGY, vol. Vol. 124, Issue 4, JPN6024052523, 2005, pages 569 - 575, ISSN: 0005739085 *
WANG, L.W., ET AL.: "Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation", CELL METABOLISM, vol. Vol. 30, Issue 3, JPN6024052521, 2019, pages 539 - 555, ISSN: 0005739086 *

Also Published As

Publication number Publication date
WO2025105377A1 (ja) 2025-05-22
JP7791559B2 (ja) 2025-12-24

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR102022017795A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13141U (https=)
BY13151U (https=)
BY13137U (https=)
BY13138U (https=)
BY13166U (https=)
BY13140U (https=)
BY13164U (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250613

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250613

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20250613

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20250701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250703

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251125

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251204

R150 Certificate of patent or registration of utility model

Ref document number: 7791559

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150